Table 2 Baseline characteristics of patients with or without achieving textbook outcome after laparoscopic pancreaticoduodenectomy
Variables | TO (+) (n = 165, 82.5%) | TO (-) (n = 35, 17.5%) | P |
|---|---|---|---|
Age (years)* | 59.6(9.4) | 57.4(13.2) | 0.338 |
Sex (M) (n, %) | 88 (53.3%) | 26(74.3%) | 0.023 |
BMI (kg/m2) * | 22.6(3.2) | 23.0(3.6) | 0.542 |
ASA score | 0.724 | ||
II (n, %) | 108(65.5%) | 24(68.6%) | - |
III (n, %) | 57(34.5%) | 11(31.4%) | - |
APTT† | 27.1(25.7–28.9) | 28.3(26.3–30.3) | 0.029 |
PT† | 11.4(10.8–12.1) | 11.5(11.0-12.3) | 0.453 |
Hemoglobin (g/L) * | 122.2(21.8) | 128.7(23.5) | 0.114 |
Albumin (g/L) * | 39.5(5.3) | 38.8(4.5) | 0.439 |
Creatinine (µmol/L) † | 64.0(56.0–78.0) | 69.0(62.0–82.0) | 0.043 |
Total bilirubin (µmol/L) † | 16.1(10.1–97.3) | 16.9(8.7-121.8) | 0.922 |
Biliary drainage (n, %) | 32(19.4%) | 8(22.9%) | 0.642 |
Tumor size (cm)† | 2.8(2.0-3.6) | 2.5(2.0-3.5) | 0.501 |
OT (min)* | 305.3(69.3) | 307.0(75.8) | 0.896 |
EBL (mL)† | 100.0(100.0-200.0) | 150.0(100.0-200.0) | 0.078 |
Blood transfusion (n, %) | 14(8.5%) | 5(14.3%) | 0.456 |
Time of PJ (min)† | 22.0(17.5–29.5) | 21.0(18.0–28.0) | 0.553 |
MPD stent (Y) (n, %) | 86 (52.1%) | 15(42.9%) | 0.319 |
Pancreatic texture | 0.005 | ||
Soft (n, %) | 80(48.5%) | 26(74.3%) | - |
Hard (n, %) | 85(51.5%) | 9(25.7%) | - |
Diameter of MPD (mm)† | 4.0(3.0–5.0) | 3.0(2.0–4.0) | 0.027 |
Postoperative hospital stays (d) | 15.8(8.2) | 29.0(14.0) | < 0.001 |
Diagnosis (n, %) | |||
Duodenum cancer | 7(4.2%) | 5(14.3%) | 0.002 |
Pancreatic cancer | 61(37.0%) | 3(8.6%) | |
Distal biliary duct cancer | 14(8.5%) | 5(14.3%) | |
Ampullary cancer | 33(20.0%) | 3(8.6%) | |
Pancreatic cystic tumors | 24(14.5%) | 9(25.7%) | |
Chronic Pancreatitis | 11(6.7%) | 5(14.3%) | |
Others§ | 15(9.1%) | 5(14.3%) | |
Pathological outcomes (n, %) | 0.098 | ||
Malignant | 126(76.3%) | 22(62.9%) | - |
Benign | 39(23.6%) | 13(37.1%) | - |